Rigel Pharmaceuticals, Inc. (RIGL) — Analyst estimates
Consensus analyst estimates for Rigel Pharmaceuticals, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 83.18M | 1.16 | 1 |
| 2027 | 96.28M | 1.2 | 1 |
| 2028 | 397.34M | 5.07 | 4 |
| 2029 | 422.55M | 4.07 | 2 |
| 2030 | 463.81M | 4.61 | 2 |
Consensus analyst estimates by fiscal year.